Vanguard Group’s MediciNova MNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$924K Buy
705,625
+5,240
+0.7% +$7.23K ﹤0.01% 3791
2025
Q3
$882K Buy
700,385
+13,808
+2% +$17.9K ﹤0.01% 3820
2025
Q2
$899K Buy
686,577
+63,003
+10% +$88.2K ﹤0.01% 3770
2025
Q1
$910K Buy
623,574
+241
+0% +$426 ﹤0.01% 3741
2024
Q4
$1.31M Hold
623,333
﹤0.01% 3679
2024
Q3
$1.31M Hold
623,333
﹤0.01% 3690
2024
Q2
$898K Hold
623,333
﹤0.01% 3822
2024
Q1
$904K Hold
623,333
﹤0.01% 3850
2023
Q4
$935K Buy
623,333
+6,490
+1% +$11.7K ﹤0.01% 3848
2023
Q3
$1.29M Hold
616,843
﹤0.01% 3744
2023
Q2
$1.42M Sell
616,843
-8,988
-1% -$19.8K ﹤0.01% 3784
2023
Q1
$1.35M Hold
625,831
﹤0.01% 3813
2022
Q4
$1.28M Sell
625,831
-1,201,901
-66% -$2.65M ﹤0.01% 3825
2022
Q3
$3.97M Hold
1,827,732
﹤0.01% 3436
2022
Q2
$4.62M Hold
1,827,732
﹤0.01% 3416
2022
Q1
$4.88M Sell
1,827,732
-9,449
-0.5% -$23.1K ﹤0.01% 3542
2021
Q4
$4.92M Buy
1,837,181
+10,529
+0.6% +$35.2K ﹤0.01% 3613
2021
Q3
$6.92M Sell
1,826,652
-80
-0% -$304 ﹤0.01% 3460
2021
Q2
$7.76M Sell
1,826,732
-340,171
-16% -$1.47M ﹤0.01% 3344
2021
Q1
$10.9M Buy
2,166,903
+202,427
+10% +$1.18M ﹤0.01% 3100
2020
Q4
$10.3M Buy
1,964,476
+64,837
+3% +$372K ﹤0.01% 2973
2020
Q3
$9.95M Sell
1,899,639
-28,164
-1% -$162K ﹤0.01% 2797
2020
Q2
$10.4M Buy
1,927,803
+34,879
+2% +$185K ﹤0.01% 2746
2020
Q1
$7.04M Buy
1,892,924
+65,582
+4% +$341K ﹤0.01% 2792
2019
Q4
$12.3M Buy
1,827,342
+113,309
+7% +$852K ﹤0.01% 2758
2019
Q3
$13.6M Buy
1,714,033
+49,508
+3% +$441K ﹤0.01% 2662
2019
Q2
$16M Buy
1,664,525
+16,021
+1% +$169K ﹤0.01% 2625
2019
Q1
$13.6M Buy
1,648,504
+47,549
+3% +$415K ﹤0.01% 2669
2018
Q4
$13.1M Buy
1,600,955
+16,802
+1% +$168K ﹤0.01% 2643
2018
Q3
$19.8M Buy
1,584,153
+22,432
+1% +$225K ﹤0.01% 2580
2018
Q2
$12.4M Buy
1,561,721
+66,990
+4% +$693K ﹤0.01% 2791
2018
Q1
$15.3M Buy
1,494,731
+230,779
+18% +$2.3M ﹤0.01% 2607
2017
Q4
$8.18M Buy
1,263,952
+40,892
+3% +$271K ﹤0.01% 2913
2017
Q3
$7.79M Buy
1,223,060
+25,344
+2% +$135K ﹤0.01% 2934
2017
Q2
$6.3M Buy
1,197,716
+12,249
+1% +$68.7K ﹤0.01% 2999
2017
Q1
$7.1M Buy
1,185,467
+32,091
+3% +$193K ﹤0.01% 2916
2016
Q4
$6.96M Buy
1,153,376
+33,473
+3% +$236K ﹤0.01% 2902
2016
Q3
$8.39M Buy
1,119,903
+20,644
+2% +$139K ﹤0.01% 2769
2016
Q2
$8.3M Buy
1,099,259
+148,299
+16% +$1.07M ﹤0.01% 2734
2016
Q1
$6.98M Buy
950,960
+462,301
+95% +$2.29M ﹤0.01% 2794
2015
Q4
$1.74M Buy
488,659
+3,900
+0.8% +$12.4K ﹤0.01% 3446
2015
Q3
$1.38M Buy
484,759
+33,197
+7% +$113K ﹤0.01% 3535
2015
Q2
$1.78M Buy
451,562
+23,747
+6% +$93.8K ﹤0.01% 3464
2015
Q1
$1.51M Buy
427,815
+12,094
+3% +$43K ﹤0.01% 3508
2014
Q4
$1.26M Buy
415,721
+35,029
+9% +$119K ﹤0.01% 3449
2014
Q3
$1.14M Buy
380,692
+7,150
+2% +$16.3K ﹤0.01% 3466
2014
Q2
$758K Buy
373,542
+15,800
+4% +$30.8K ﹤0.01% 3559
2014
Q1
$741K Buy
357,742
+114,980
+47% +$256K ﹤0.01% 3547
2013
Q4
$520K Hold
242,762
﹤0.01% 3586
2013
Q3
$612K Hold
242,762
﹤0.01% 3500
2013
Q2
$638K Buy
+242,762
New +$716K ﹤0.01% 3419

Other funds holding MNOV

Vanguard Group's MNOV Position: Q4 2025 in Review

Vanguard Group increased its MediciNova (MNOV) stake by 0.75% in Q4 2025, buying an estimated $7.23K and bringing the position to 705,625 shares worth $924K. The position accounts for ﹤0.01% of the portfolio, ranked #3791.

Vanguard Group first reported a position in MNOV in Q2 2013 and has held it in 51 quarters since. The position peaked at $19.8M in Q3 2018. 33 funds tracked by Wall St. Rank hold MNOV as of Q4 2025.

  • Vanguard Group held 705,625 shares of MediciNova worth $924K as of Q4 2025.
  • Vanguard Group bought 5,240 MediciNova shares in Q4 2025, an estimated $7.23K.
  • MediciNova made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3791 holding.
  • Vanguard Group first reported a position in MediciNova in Q2 2013 and has held it in 51 quarters since.
  • Vanguard Group's MediciNova position peaked at $19.8M in Q3 2018.
  • 33 funds tracked by Wall St. Rank held MediciNova as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.